探索布洛芬的心血管安全概况:来自EudraVigilance数据库的见解
Cristina Anamaria Buciuman1, Carmen Maximiliana Dobrea2, Anca Butuca2
1Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Str., 020956 Bucharest, Romania.
Pharmaceuticals (Basel, Switzerland)
|July 30, 2025
概括
这项研究发现,与其他非类固醇抗炎药物 (NSAIDs) 相比,易布洛芬的心血管不良反应报告概率较低. 建议进行进一步的临床研究,以充分了解易布洛芬.
科学领域:
- 药物监督 药物监督 药物监督
- 心血管安全心血管安全
- 药物安全评估 药物安全评估
背景情况:
- 布洛芬是一种广泛可用的非类固醇抗炎药物 (NSAID),具有非选择性的COX抑制.
- 已知的不良反应包括胃肠道,脏,血液和心血管的影响.
- 鉴于易布洛芬的常见使用,评估现实世界的心血管安全至关重要.
研究的目的:
- 为了评估ibuprofen的真实心血管安全概况.
- 为了比较布洛芬与其他NSAID和组合产品之间的心血管风险.
- 利用药监数据进行全面的安全评估.
主要方法:
- 采用描述性和基于不成比例的药监方法.
- 分析了EudraVigilance数据库中的58,760个与布洛芬相关的病例.
- 选择了40种心血管效应描述剂,并使用了8种NSAID和易布洛芬/伪乙作为比较剂.
主要成果:
- 与埃托利科西布,塞莱科西布,梅洛西卡姆,乙酸盐和布洛芬/伪相比,布洛芬的中风概率较低.
- 据报道,仅与基托相比,布洛芬的血栓形成概率更高.
- 与某些其他NSAID相比,在ibuprofen中观察到高血压和心肌梗塞的可能性增加.
结论:
- 该研究表明,与其他NSAID相比,ibuprofen的心血管不良反应概率可能更低.
- 药监数据固有的局限性要求谨慎解释研究结果.
- 进一步的临床研究对于明确了解布洛芬的心血管安全至关重要.
相关概念视频
Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
646
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
646
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
599
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
599
Therapeutic Index
5.1K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
5.1K
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K


